Bard Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bard Financial Services's BMY Position: Q3 2025 in Review
Bard Financial Services increased its Bristol-Myers Squibb (BMY) stake by 3.8% in Q3 2025, buying an estimated $72.4K and bringing the position to 42,860 shares worth $1.93M. The position accounts for 0.21% of the portfolio, ranked #90.
Bard Financial Services first reported a position in BMY in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.13M in Q2 2022. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Bard Financial Services held 42,860 shares of Bristol-Myers Squibb worth $1.93M as of Q3 2025.
- Bard Financial Services bought 1,550 Bristol-Myers Squibb shares in Q3 2025, an estimated $72.4K.
- Bristol-Myers Squibb made up 0.21% of Bard Financial Services's portfolio in Q3 2025, its #90 holding.
- Bard Financial Services first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 20 quarters since.
- Bard Financial Services's Bristol-Myers Squibb position peaked at $5.13M in Q2 2022.
- 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Bard Financial Services's 13F filing for Q3 2025, filed 17 Oct 2025.